Sino Biological Inc. logo

Sino Biological Inc. (301047)

Market Open
11 Aug, 05:59
XSHE XSHE
¥
120. 01
+6.4
+5.6333%
¥
8.31B Market Cap
- P/E Ratio
16% Div Yield
20.6M Volume
- Eps
¥ 113.61
Previous Close
Add Transaction
Day Range
116.32 126.66
Year Range
58.05 129.39
Want to track 301047 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

301047 trading today higher at ¥120.01, an increase of 5.6333% from yesterday's close, completing a monthly increase of 86.6407% or ¥55.71. Over the past 12 months, 301047 stock gained 77.0059%.
301047 is not paying dividends to its shareholders.
The last earnings report, released on Apr 23, 2024, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0.2691%, based on the last three reports.
Sino Biological Inc. has completed 1 stock splits, with the recent split occurring on Mar 30, 2022.
The company's stock is traded on one exchange.

301047 Chart

People also search for

Guangzhou Wondfo Biotech Co., Ltd.
¥ 17.89
0%
China Reform Health Management Co., Ltd.
¥ 7.52
-0.2653%
Acro Biosystems Co., Ltd.
¥ 81.88
+5.3797%
EIT Environmental Development Group Co., Ltd.
¥ 16.54
-1.0174%
Huapont Life Sciences Co., Ltd.
¥ 4.5
+0.6711%

Sino Biological Inc. (301047) FAQ

What is the stock price today?

The current price is ¥120.01.

On which exchange is it traded?

Sino Biological Inc. is listed on XSHE.

What is its stock symbol?

The ticker symbol is 301047.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 16%.

What is its market cap?

As of today, the market cap is 8.31B.

Has Sino Biological Inc. ever had a stock split?

Sino Biological Inc. had 1 splits and the recent split was on Mar 30, 2022.

Sino Biological Inc. Profile

Biotechnology Industry
Healthcare Sector
Dr. Liangzhi Xie Ph.D. CEO
XSHE Exchange
- ISIN
CN Country
1,021 Employees
15 May 2026 Last Dividend
30 Mar 2022 Last Split
- IPO Date

Overview

Sino Biological, Inc. is a prominent provider of recombinant protein and antibody reagents designed to meet the needs of life science researchers across the globe. Since its establishment in 2016, the company has positioned itself as a key player in the biotechnology field, supplying a wide range of high-quality products and services. Operating out of its headquartered in Beijing, China, Sino Biological caters to various sectors within the scientific community, including academic research institutions, biotech companies, and pharmaceutical corporations. The company's mission is to accelerate the pace of scientific discovery by offering reliable and innovative solutions that facilitate research in critical areas such as cancer research, cardiovascular biology, and neurosciences among others.

Products and Services

Recombinant Proteins: Sino Biological offers an extensive catalog of high-quality recombinant proteins to support research in areas such as immunology, cancer, and stem cells. These proteins are essential tools for understanding disease mechanisms and developing therapeutic strategies.

Antibodies: The company provides a broad range of antibodies, including monoclonal, polyclonal, and conjugated antibodies. These are carefully developed to ensure high specificity and sensitivity for various applications in cell signaling, neuroscience, and more.

cDNA Clones: Sino Biological’s collection of cDNA clones is an invaluable resource for gene expression studies, enabling researchers to investigate gene function and regulation across a variety of organisms and conditions.

Kits: The company produces kits designed for the precise detection and quantification of biological substances. These kits simplify complex analyses in areas such as epigenetics and cell biology.

Custom Services: Beyond its extensive product offerings, Sino Biological also provides custom services tailored to meet specific research needs. These services include protein production, antibody development and production, biological assay, and protein expression services.

Pre-Clinical Production Technology Services: Sino Biological offers technology services for the pre-clinical production of monoclonal antibody drug candidates, facilitating the development of next-generation therapeutics.

Contact Information

Address: Building 11, Beijing, China, 100176
Phone: 86 40 0890 9989